Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
L. Spicuzza (CATANIA, Italy), E. Frasca (CATANIA, Italy), G. Doria (cATANIA, Italy), G. Cacopardo (CATANIA, Italy), C. Crimi (CATANIA, Italy), R. Campisi (CATANIA, Italy), N. Crimi (CATANIA, Italy), G. Di Maria (CATANIA, Italy)
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Disease area: Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Spicuzza (CATANIA, Italy), E. Frasca (CATANIA, Italy), G. Doria (cATANIA, Italy), G. Cacopardo (CATANIA, Italy), C. Crimi (CATANIA, Italy), R. Campisi (CATANIA, Italy), N. Crimi (CATANIA, Italy), G. Di Maria (CATANIA, Italy). Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.. 2493
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012
Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Prevalence of obstructive airway disease in patients with obstructive sleep apnea Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA Year: 2012
Chronic obstructive pulmonary disease in patients with obstructive sleep apnea Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009
Efficacy of AUTO-CPAP titration in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 390s Year: 2001
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007
Sleep disorders in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020
The difference in obstructive sleep apnoea symptoms between patients with obstructive and inflammatory diseases Source: Eur Respir J 2005; 26: Suppl. 49, 65s Year: 2005
Prevalence and characteristics of patients with obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD): “overlap syndrome (OS)” Source: Virtual Congress 2020 – Prevalence, characteristics and predictors of obstructive sleep apnoea Year: 2020
Prevalence of thyroid disease in patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011
A comparison of pulmonary function, functional exercise capacity and sleep quality in patients with chronic obstructive pulmonary disease and obstructive sleep apnea syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012
Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010
Sleep in chronic obstructive disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=325 Year: 2006
The difference in obstructive sleep apnoea symptoms between patients with pulmonary and extra pulmonary inflammatory diseases Source: Eur Respir J 2006; 28: Suppl. 50, 644s Year: 2006
Unrecognised systemic hypertension in patients with obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 643s Year: 2006
Prevalence of comorbidity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001
Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 645s Year: 2006
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Assessment of the prevalence of obstructive sleep apnea in patients with undiagnosed chronic cough Source: Annual Congress 2012 - Sleep disorders in internal medicine Year: 2012
Is obstructive sleep apnoea a comorbidity of COPD and is it involved in chronic systemic inflammatory syndrome? Source: Eur Respir J 2008; 31: 1381-1382 Year: 2008